Matt Kumeta

Matt Kumeta
T: +44 (0) 121 654 5013
E: matt.kumeta@alantra.com

Matt is an Analyst at Alantra.

His chief responsibilities are to produce detailed analysis of transaction trends and to provide bespoke research to support business development and deal delivery. 

Matt is a member of the Healthcare sector team. He also has a focus on our business development activities in the East Midlands. Recent deals include advising on the sale of 4Ways, the acquisition of Cornerstone Healthcare Group, and advising Spectris plc on its £163m acquisition of Concept Life Sciences.

Matt has a MSc (Distinction) in Banking & Finance from Queen Mary, University of London and an undergraduate degree in Money Banking & Finance from the University of Birmingham.

When he's not at work, Matt enjoys playing golf, squash and hockey and is a member of Edgbaston's hockey club. He also likes watching rugby and playing the guitar and saxophone.

Alantra advises Inflexion and Vivona Brands on sale to Webster Equity Partners

Alantra has advised Inflexion and Vivona Brands (“Vivona”) on the sale of the business to US based private equity firm, Webster Equity Partners.  

Alantra named as ‘European Corporate Finance House of the Year 2019′

Alantra has won the European Corporate Finance House of the Year Award at The Private Equity Awards 2019, hosted by Real Deals. 

Alantra advises Altius on investment by MML Capital Partners

Alantra has advised high-growth data consultancy, Altius, on investment by MML Capital Partners. 

Alantra advises Livingbridge on investment in leading management consultancy

Alantra has advised private equity firm Livingbridge on its investment in Vendigital, leading management consultancy provider. 

Alantra advises ParkJockey on investment from leading technology investment fund and subsequent parking operator acquisitions

Alantra has advised ParkJockey, a provider of a next-generation technology platform aimed at optimising parking real estate, on securing an investment from a leading global technology investment fund.